Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012)

Tg Therapeutics (TGTX) posted quarterly Preferred Shares of $1109.0 for Q1 2012, up 168.52% quarter-over-quarter from $413.0 in Q4 2011.

Tg Therapeutics (TGTX) Preferred Shares (2011 - 2012) Analysis & Trends

Tg Therapeutics' Preferred Shares history runs 2 years deep, the most recent figure standing at $1109.0 for Q1 2012.

In Q1 2012, Preferred Shares changed N/A year-over-year to $1109.0; the TTM figure through Mar 2012 stood at $1109.0 (changed N/A YoY), while the FY2012 annual figure was $1109.0, changed N/A from the prior year.
Preferred Shares for Q1 2012 stood at $1109.0, up from $413.0 in the prior quarter.
The five-year high for Preferred Shares was $1109.0 in Q1 2012, with the low at $413.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Tg Therapeutics	7.46 Bn	6.78 Bn	199.14 Mn	-

Download Data

Date	Value
Mar 31, 2012	1,109.00
Dec 31, 2011	413.00